TGOPY
Get informed when a big investor buys or sells
+ FollowOvervalued by 96.4% based on the discounted cash flow analysis.
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.28 (3.24%) |
| Earnings per Share | $1.38 |
| Beta | 1.12 |
| Outstanding Shares | 4,071,326,000 |
| P/E Ratio | 4.86 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.02%▲ 0.01% |
|---|---|
| Total Invested | $2.63M▲ 26.94% |
| Investors Holding | 9▼ 4.00% |
No data
No data
This committee provides the official revenue estimates and technical analysis for all tax legislation. Its work directly shapes and influences the tax environment, which is critical for 3i Group's structure, investment returns, and the profitability of its portfolio companies.
This committee is paramount for a private equity firm, controlling taxation (including corporate tax rates and treatment of carried interest), trade policy affecting global operations, and entitlement spending, all of which directly drive corporate valuations and profitability for 3i Group and its portfolio.
This committee directly allocates discretionary federal spending. Its decisions determine the specific cash flow for government programs, infrastructure projects, and scientific research, directly impacting the revenue and order books of many companies within 3i Group's investment universe.
This committee regulates key sectors for 3i Group, such as healthcare (FDA, NIH affecting pharma/biotech valuations) and labor laws, which influence operating costs across all of 3i's portfolio companies.
As an active M&A player, 3i Group is directly impacted by this committee's oversight of antitrust laws, which dictates the viability and conditions of mergers and acquisitions, and intellectual property protection crucial for many portfolio companies.
This committee directly regulates the financial system, including the Fed and SEC, which critically impacts fundraising, capital requirements, and overall market stability for a private equity firm. Its influence on real estate and cryptocurrency regulation also directly affects 3i Group's investment areas.
This committee drafts the federal budget, influencing the macroeconomic environment, interest rates, and government spending on projects relevant to 3i's infrastructure investments. It directly affects the overall financial market conditions and sovereign debt levels.
3i Group's infrastructure investments often include energy assets (e.g., renewables). This committee's direct oversight of national energy policy, public lands, and resource development critically impacts these investment areas.
3i Group invests significantly in infrastructure. This committee directly influences federal infrastructure programs and environmental regulations that critically impact the valuation and operational costs of 3i's infrastructure assets and portfolio companies.
As a global private equity firm, 3i Group's international investments and portfolio companies are highly susceptible to changes in U.S. foreign policy, sanctions, and global market stability, which this committee directly influences.